Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Meningococcal Vaccine Market, by Brand
1.4.2 Global Meningococcal Vaccine Market, by Type
1.4.3 Global Meningococcal Vaccine Market, by Age Group
1.4.4 Global Meningococcal Vaccine Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Recent Developments in Meningococcal Vaccine Market
Chapter 4. Global Meningococcal Vaccine Market by Brand
4.1 Global Bexsero Market by Region
4.2 Global Trumenba Market by Region
4.3 Global Nimenrix Market by Region
4.4 Global Menactra Market by Region
4.5 Global Menveo Market by Region
4.6 Global Other Brands Market by Region
Chapter 5. Global Meningococcal Vaccine Market by Type
5.1 Global Bivalent Market by Region
5.2 Global Quadrivalent Market by Region
5.3 Global Other Types Market by Region
Chapter 6. Global Meningococcal Vaccine Market by Age Group
6.1 Global Children (2 years & above) and Adults Market by Region
6.2 Global Infants(0 to 2 years) Market by Region
Chapter 7. Global Meningococcal Vaccine Market by Region
7.1 North America Meningococcal Vaccine Market
7.1.1 North America Meningococcal Vaccine Market by Brand
7.1.1.1 North America Bexsero Market by Country
7.1.1.2 North America Trumenba Market by Country
7.1.1.3 North America Nimenrix Market by Country
7.1.1.4 North America Menactra Market by Country
7.1.1.5 North America Menveo Market by Country
7.1.1.6 North America Other Brands Market by Country
7.1.2 North America Meningococcal Vaccine Market by Type
7.1.2.1 North America Bivalent Market by Country
7.1.2.2 North America Quadrivalent Market by Country
7.1.2.3 North America Other Types Market by Country
7.1.3 North America Meningococcal Vaccine Market by Age Group
7.1.3.1 North America Children (2 years & above) and Adults Market by Country
7.1.3.2 North America Infants(0 to 2 years) Market by Country
7.1.4 North America Meningococcal Vaccine Market by Country
7.1.4.1 USA Meningococcal Vaccine Market
7.1.4.1.1 USA Meningococcal Vaccine Market by Brand
7.1.4.1.2 USA Meningococcal Vaccine Market by Type
7.1.4.1.3 USA Meningococcal Vaccine Market by Age Group
7.1.4.2 Canada Meningococcal Vaccine Market
7.1.4.2.1 Canada Meningococcal Vaccine Market by Brand
7.1.4.2.2 Canada Meningococcal Vaccine Market by Type
7.1.4.2.3 Canada Meningococcal Vaccine Market by Age Group
7.1.4.3 Mexico Meningococcal Vaccine Market
7.1.4.3.1 Mexico Meningococcal Vaccine Market by Brand
7.1.4.3.2 Mexico Meningococcal Vaccine Market by Type
7.1.4.3.3 Mexico Meningococcal Vaccine Market by Age Group
7.1.4.4 Rest of North America Meningococcal Vaccine Market
7.1.4.4.1 Rest of North America Meningococcal Vaccine Market by Brand
7.1.4.4.2 Rest of North America Meningococcal Vaccine Market by Type
7.1.4.4.3 Rest of North America Meningococcal Vaccine Market by Age Group
7.2 Europe Meningococcal Vaccine Market
7.2.1 Europe Meningococcal Vaccine Market by Brand
7.2.1.1 Europe Bexsero Market by Country
7.2.1.2 Europe Trumenba Market by Country
7.2.1.3 Europe Nimenrix Market by Country
7.2.1.4 Europe Menactra Market by Country
7.2.1.5 Europe Menveo Market by Country
7.2.1.6 Europe Other Brands Market by Country
7.2.2 Europe Meningococcal Vaccine Market by Type
7.2.2.1 Europe Bivalent Market by Country
7.2.2.2 Europe Quadrivalent Market by Country
7.2.2.3 Europe Other Types Market by Country
7.2.3 Europe Meningococcal Vaccine Market by Age Group
7.2.3.1 Europe Children (2 years & above) and Adults Market by Country
7.2.3.2 Europe Infants(0 to 2 years) Market by Country
7.2.4 Europe Meningococcal Vaccine Market by Country
7.2.4.1 Germany Meningococcal Vaccine Market
7.2.4.1.1 Germany Meningococcal Vaccine Market by Brand
7.2.4.1.2 Germany Meningococcal Vaccine Market by Type
7.2.4.1.3 Germany Meningococcal Vaccine Market by Age Group
7.2.4.2 UK Meningococcal Vaccine Market
7.2.4.2.1 UK Meningococcal Vaccine Market by Brand
7.2.4.2.2 UK Meningococcal Vaccine Market by Type
7.2.4.2.3 UK Meningococcal Vaccine Market by Age Group
7.2.4.3 France Meningococcal Vaccine Market
7.2.4.3.1 France Meningococcal Vaccine Market by Brand
7.2.4.3.2 France Meningococcal Vaccine Market by Type
7.2.4.3.3 France Meningococcal Vaccine Market by Age Group
7.2.4.4 Russia Meningococcal Vaccine Market
7.2.4.4.1 Russia Meningococcal Vaccine Market by Brand
7.2.4.4.2 Russia Meningococcal Vaccine Market by Type
7.2.4.4.3 Russia Meningococcal Vaccine Market by Age Group
7.2.4.5 Spain Meningococcal Vaccine Market
7.2.4.5.1 Spain Meningococcal Vaccine Market by Brand
7.2.4.5.2 Spain Meningococcal Vaccine Market by Type
7.2.4.5.3 Spain Meningococcal Vaccine Market by Age Group
7.2.4.6 Italy Meningococcal Vaccine Market
7.2.4.6.1 Italy Meningococcal Vaccine Market by Brand
7.2.4.6.2 Italy Meningococcal Vaccine Market by Type
7.2.4.6.3 Italy Meningococcal Vaccine Market by Age Group
7.2.4.7 Rest of Europe Meningococcal Vaccine Market
7.2.4.7.1 Rest of Europe Meningococcal Vaccine Market by Brand
7.2.4.7.2 Rest of Europe Meningococcal Vaccine Market by Type
7.2.4.7.3 Rest of Europe Meningococcal Vaccine Market by Age Group
7.3 Asia Pacific Meningococcal Vaccine Market
7.3.1 Asia Pacific Meningococcal Vaccine Market by Brand
7.3.1.1 Asia Pacific Bexsero Market by Country
7.3.1.2 Asia Pacific Trumenba Market by Country
7.3.1.3 Asia Pacific Nimenrix Market by Country
7.3.1.4 Asia Pacific Menactra Market by Country
7.3.1.5 Asia Pacific Menveo Market by Country
7.3.1.6 Asia Pacific Other Brands Market by Country
7.3.2 Asia Pacific Meningococcal Vaccine Market by Type
7.3.2.1 Asia Pacific Bivalent Market by Country
7.3.2.2 Asia Pacific Quadrivalent Market by Country
7.3.2.3 Asia Pacific Other Types Market by Country
7.3.3 Asia Pacific Meningococcal Vaccine Market by Age Group
7.3.3.1 Asia Pacific Children (2 years & above) and Adults Market by Country
7.3.3.2 Asia Pacific Infants(0 to 2 years) Market by Country
7.3.4 Asia Pacific Meningococcal Vaccine Market by Country
7.3.4.1 China Meningococcal Vaccine Market
7.3.4.1.1 China Meningococcal Vaccine Market by Brand
7.3.4.1.2 China Meningococcal Vaccine Market by Type
7.3.4.1.3 China Meningococcal Vaccine Market by Age Group
7.3.4.2 India Meningococcal Vaccine Market
7.3.4.2.1 India Meningococcal Vaccine Market by Brand
7.3.4.2.2 India Meningococcal Vaccine Market by Type
7.3.4.2.3 India Meningococcal Vaccine Market by Age Group
7.3.4.3 Japan Meningococcal Vaccine Market
7.3.4.3.1 Japan Meningococcal Vaccine Market by Brand
7.3.4.3.2 Japan Meningococcal Vaccine Market by Type
7.3.4.3.3 Japan Meningococcal Vaccine Market by Age Group
7.3.4.4 South Korea Meningococcal Vaccine Market
7.3.4.4.1 South Korea Meningococcal Vaccine Market by Brand
7.3.4.4.2 South Korea Meningococcal Vaccine Market by Type
7.3.4.4.3 South Korea Meningococcal Vaccine Market by Age Group
7.3.4.5 Singapore Meningococcal Vaccine Market
7.3.4.5.1 Singapore Meningococcal Vaccine Market by Brand
7.3.4.5.2 Singapore Meningococcal Vaccine Market by Type
7.3.4.5.3 Singapore Meningococcal Vaccine Market by Age Group
7.3.4.6 Malaysia Meningococcal Vaccine Market
7.3.4.6.1 Malaysia Meningococcal Vaccine Market by Brand
7.3.4.6.2 Malaysia Meningococcal Vaccine Market by Type
7.3.4.6.3 Malaysia Meningococcal Vaccine Market by Age Group
7.3.4.7 Rest of Asia Pacific Meningococcal Vaccine Market
7.3.4.7.1 Rest of Asia Pacific Meningococcal Vaccine Market by Brand
7.3.4.7.2 Rest of Asia Pacific Meningococcal Vaccine Market by Type
7.3.4.7.3 Rest of Asia Pacific Meningococcal Vaccine Market by Age Group
7.4 LAMEA Meningococcal Vaccine Market
7.4.1 LAMEA Meningococcal Vaccine Market by Brand
7.4.1.1 LAMEA Bexsero Market by Country
7.4.1.2 LAMEA Trumenba Market by Country
7.4.1.3 LAMEA Nimenrix Market by Country
7.4.1.4 LAMEA Menactra Market by Country
7.4.1.5 LAMEA Menveo Market by Country
7.4.1.6 LAMEA Other Brands Market by Country
7.4.2 LAMEA Meningococcal Vaccine Market by Type
7.4.2.1 LAMEA Bivalent Market by Country
7.4.2.2 LAMEA Quadrivalent Market by Country
7.4.2.3 LAMEA Other Types Market by Country
7.4.3 LAMEA Meningococcal Vaccine Market by Age Group
7.4.3.1 LAMEA Children (2 years & above) and Adults Market by Country
7.4.3.2 LAMEA Infants(0 to 2 years) Market by Country
7.4.4 LAMEA Meningococcal Vaccine Market by Country
7.4.4.1 Brazil Meningococcal Vaccine Market
7.4.4.1.1 Brazil Meningococcal Vaccine Market by Brand
7.4.4.1.2 Brazil Meningococcal Vaccine Market by Type
7.4.4.1.3 Brazil Meningococcal Vaccine Market by Age Group
7.4.4.2 Argentina Meningococcal Vaccine Market
7.4.4.2.1 Argentina Meningococcal Vaccine Market by Brand
7.4.4.2.2 Argentina Meningococcal Vaccine Market by Type
7.4.4.2.3 Argentina Meningococcal Vaccine Market by Age Group
7.4.4.3 UAE Meningococcal Vaccine Market
7.4.4.3.1 UAE Meningococcal Vaccine Market by Brand
7.4.4.3.2 UAE Meningococcal Vaccine Market by Type
7.4.4.3.3 UAE Meningococcal Vaccine Market by Age Group
7.4.4.4 Saudi Arabia Meningococcal Vaccine Market
7.4.4.4.1 Saudi Arabia Meningococcal Vaccine Market by Brand
7.4.4.4.2 Saudi Arabia Meningococcal Vaccine Market by Type
7.4.4.4.3 Saudi Arabia Meningococcal Vaccine Market by Age Group
7.4.4.5 South Africa Meningococcal Vaccine Market
7.4.4.5.1 South Africa Meningococcal Vaccine Market by Brand
7.4.4.5.2 South Africa Meningococcal Vaccine Market by Type
7.4.4.5.3 South Africa Meningococcal Vaccine Market by Age Group
7.4.4.6 Nigeria Meningococcal Vaccine Market
7.4.4.6.1 Nigeria Meningococcal Vaccine Market by Brand
7.4.4.6.2 Nigeria Meningococcal Vaccine Market by Type
7.4.4.6.3 Nigeria Meningococcal Vaccine Market by Age Group
7.4.4.7 Rest of LAMEA Meningococcal Vaccine Market
7.4.4.7.1 Rest of LAMEA Meningococcal Vaccine Market by Brand
7.4.4.7.2 Rest of LAMEA Meningococcal Vaccine Market by Type
7.4.4.7.3 Rest of LAMEA Meningococcal Vaccine Market by Age Group
Chapter 8. Company Profiles
8.1 GlaxoSmithKline PLC (GSK)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Approvals:
8.2 Pfizer, Inc.
8.2.1 Company Overview
8.2.1 Financial Analysis
8.2.2 Segmental and Regional Analysis
8.2.3 Recent strategies and developments:
8.2.3.1 Approvals:
8.3 Sanofi S.A.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Approvals:
8.4 Walvax Biotechnology Co., Ltd.
8.4.1 Company Overview
8.5 Bio-Manguinhos (Oswaldo Cruz Foundation)
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Partnerships, Collaborations, and Agreements:
8.6 Bio-Med Pvt. Ltd.
8.6.1 Company Overview
8.7 Chongqing Zhifei Biological Products Co., Ltd.
8.7.1 Company Overview
8.8 Hualan Biological Engineering, Inc.
8.8.1 Company Overview
8.9 Incepta Pharmaceuticals Ltd.
8.9.1 Company Overview
8.10. Serum Institute of India Pvt. Ltd. (Poonawalla Investments & Industries Pvt. Ltd.)
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Product Launches and Product Expansions:
Unique Offerings 
